[go: up one dir, main page]

MX347513B - Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa. - Google Patents

Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Info

Publication number
MX347513B
MX347513B MX2015014313A MX2015014313A MX347513B MX 347513 B MX347513 B MX 347513B MX 2015014313 A MX2015014313 A MX 2015014313A MX 2015014313 A MX2015014313 A MX 2015014313A MX 347513 B MX347513 B MX 347513B
Authority
MX
Mexico
Prior art keywords
therapy
renal failure
blood
solute
failure blood
Prior art date
Application number
MX2015014313A
Other languages
English (en)
Inventor
Kenneth Leypoldt John
Lo Ying-Cheng
Akonur Alp
Ugar Agar Baris
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX347513B publication Critical patent/MX347513B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Arrangement Of Elements, Cooling, Sealing, Or The Like Of Lighting Devices (AREA)

Abstract

Un sistema de terapia sanguínea de falla renal incluye: (i) una máquina de terapia sanguínea de falla renal; (ii) una prescripción de terapia para un paciente tratado a través de la máquina de terapia sanguínea de falla renal para remover un soluto de la sangre del paciente; (iii) una prueba que incluye múltiples muestras de sangre tomadas en múltiplos tiempos durante una terapia de prueba para determinar los niveles de concentración del soluto a cada uno de los múltiples tiempos; y (iv) un dispositivo programado para utilizar un modelo cinético para el soluto en una primera instancia con al menos uno de los niveles de concentración del soluto para estimar al menos un parámetro estimado del paciente. El dispositivo además está programado para permitir que un usuario determine al menos uno de una duración de terapia, una frecuencia de terapia, una velocidad de flujo del dializado o una velocidad de flujo de sangre para la prescripción de terapia.
MX2015014313A 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa. MX347513B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
PCT/US2011/032736 WO2011130669A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Publications (1)

Publication Number Publication Date
MX347513B true MX347513B (es) 2017-04-28

Family

ID=44041518

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2015014313A MX347513B (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012062A MX2012012062A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012061A MX2012012061A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2022001536A MX2022001536A (es) 2010-04-16 2012-10-16 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Family Applications After (3)

Application Number Title Priority Date Filing Date
MX2012012062A MX2012012062A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012061A MX2012012061A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2022001536A MX2022001536A (es) 2010-04-16 2012-10-16 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Country Status (10)

Country Link
EP (3) EP3706134A1 (es)
JP (8) JP6018567B2 (es)
AU (2) AU2011239488B2 (es)
BR (1) BR112012026361A2 (es)
CA (2) CA2796505C (es)
CO (3) CO6660434A2 (es)
ES (2) ES2802609T3 (es)
MX (4) MX347513B (es)
NZ (2) NZ602996A (es)
WO (2) WO2011130668A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US8845570B2 (en) 2010-04-16 2014-09-30 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
JP6477704B2 (ja) * 2013-08-16 2019-03-06 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 腎不全血液療法、特に在宅血液透析のための血清カリウムの療法予測及び最適化
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
EP3539586B1 (en) 2014-10-10 2022-08-24 NxStage Medical Inc. Flow balancing methods
GB2570050B (en) 2016-07-18 2020-01-01 Nxstage Medical Inc Apparatus for controlling fluid flow in a circuit
EP3506962B1 (en) 2016-08-30 2023-11-22 NxStage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
EP3939055A1 (en) 2019-03-11 2022-01-19 Fresenius Medical Care Holdings, Inc. Techniques for determining acid-base homeostasis
CA3138773A1 (en) 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
DE69324471T2 (de) * 1992-10-13 1999-12-23 Baxter International Inc., Deerfield Fluessigkeitsentnahmemodul
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
ES2245723T5 (es) * 2002-09-05 2013-09-10 Gambro Lundia Ab Controlador para un equipo de tratamiento de sangre
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
EP1902397B1 (en) * 2005-06-09 2010-04-14 Gambro Lundia AB Medical apparatus and method for setting up a medical apparatus
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8888470B2 (en) 2007-02-27 2014-11-18 Deka Products Limited Partnership Pumping cassette
EP2174292A1 (en) * 2007-08-03 2010-04-14 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US8168063B2 (en) * 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US8062513B2 (en) * 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
JP2012505728A (ja) * 2008-10-17 2012-03-08 フレゼニウス メディカル ケア ホールディングス インコーポレイテッド 透析患者のためのリン結合剤投与量の決定方法

Also Published As

Publication number Publication date
ES2802609T3 (es) 2021-01-20
CO6620023A2 (es) 2013-02-15
JP6543279B2 (ja) 2019-07-10
MX2022001536A (es) 2022-05-26
JP2013524893A (ja) 2013-06-20
EP2558967B1 (en) 2020-04-15
JP7057321B2 (ja) 2022-04-19
CA2796496C (en) 2018-03-20
JP2024045513A (ja) 2024-04-02
AU2011239488B2 (en) 2015-05-21
ES2501715T3 (es) 2014-10-02
WO2011130668A1 (en) 2011-10-20
MX2012012062A (es) 2013-06-28
CA2796505A1 (en) 2011-10-20
CA2796496A1 (en) 2011-10-20
EP2558967A1 (en) 2013-02-20
CO6660434A2 (es) 2013-04-30
JP2019188179A (ja) 2019-10-31
JP2013524892A (ja) 2013-06-20
JP6078582B2 (ja) 2017-02-08
EP2558966B1 (en) 2014-07-16
EP3706134A1 (en) 2020-09-09
JP2015221383A (ja) 2015-12-10
JP2015165914A (ja) 2015-09-24
JP7438257B2 (ja) 2024-02-26
BR112012026361A2 (pt) 2019-09-24
AU2011239488A1 (en) 2012-11-08
JP5747072B2 (ja) 2015-07-08
MX2012012061A (es) 2013-06-28
JP6018567B2 (ja) 2016-11-02
AU2011239489B2 (en) 2015-04-02
NZ603010A (en) 2014-05-30
CA2796505C (en) 2018-12-11
AU2011239489A1 (en) 2012-11-08
JP2017094150A (ja) 2017-06-01
EP2558966A1 (en) 2013-02-20
NZ602996A (en) 2015-02-27
JP2022095842A (ja) 2022-06-28
CO6630153A2 (es) 2013-03-01
JP6043850B2 (ja) 2016-12-14
WO2011130669A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
MX2022001536A (es) Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2015012556A (es) Sistema y metodo para intercambio de dialisis peritoneal teniendo una unidad energizante reutilizable.
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
HK1165253A1 (en) Apparatus for detecting moisture for an apparatus for monitoring the access to a patient, in particular for monitoring the vascular access during extracorporeal blood treatment
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
MX2022008262A (es) Sistema y metodo para realizar modalidades de dialisis alternativa y secuencial de sangre y peritoneo.
MX361881B (es) Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
PL2564885T3 (pl) Urządzenie do pozaustrojowego oczyszczania krwi oraz sposób obliczania założonych natężeń przepływu w urządzeniu medycznym dla podawania lub pobierania płynów
FR2976814B1 (fr) Dispositif de valve hemostatique destine a l'introduction d'un materiel medical dans un patient, et procede associe
GB2469950A (en) Dialysis system with recirculating dialysis fluid
MX2019006526A (es) Control de un dispositivo de agua a traves de una interfase de usuario de maquina de dialisis.
ZA201005724B (en) Method and device for monitoring a vascular access and extracorporeal blood treatment device comprising a device for monitoring a vascular access
SG10201600502XA (en) Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
JP2013524893A5 (es)
WO2014049560A3 (en) Extracorporeal blood treatment apparatus and method of setting an extracorporeal blood treatment
BR112013007046A2 (pt) método para a otimização do consumo de dialisato em uma unidade de tratamento sanguíneo e aparato para o tratamento sanguíneo
PT2429606E (pt) Método e dispositivo para otimização de um tratamento de sangue extracorporal
ATE420678T1 (de) Dialysemaschine mit einer einrichtung zur bestimmung der dialysedosis
WO2011131358A3 (de) Verfahren und vorrichtung zur bestimmung des fistelflusses einer fistel für die dialysebehandlung
MX2013012083A (es) Biomarcadores para el tratamiento de mieloma multiple.
UA77634U (ru) Способ консервативного лечения венозных тромбозов
CN202146484U (zh) 防止血液回流的穿刺针
UA54000U (uk) Спосіб дренування черевної порожнини при перитоніті
RU2010154218A (ru) Способ лечения поздней кожной порфирии у больного зависимого от гемодиализа
关有彦 et al. CLINICAL CHARACTERISTICS OF RENAL CELL CARCINOMA IN YOUNG ADULT